New drug pricing plans will ‘damage UK biotech’
August 16, 2013Research and Development, Sales and Marketing BIA, Hunt, NHS, VBP, bates, biotech
The BioIndustry Association is warning that the government’s new drug pricing scheme could put future investment in the UK’s biotech …
Boehringer to shut down Petersburg chemicals facility
August 16, 2013Manufacturing and Production, Sales and Marketing Boehringer, Petersburg
Boehringer Ingelheim has conceded defeat in its search for a buyer for its chemicals facility in Petersburg, US, and is …
Price cut not enough for Pfizer’s Xalkori
August 16, 2013Sales and Marketing NICE, Pfizer, Xalkori, lung cancer
In final draft guidance NICE has rejected Pfizer’s new lung cancer drug Xalkori because of its high cost. The Institute …
Latest content
Boyds expands Regulatory Affairs team to support growing demand
October 16, 2026
Sterling doubles ADC manufacturing capacity at Welsh facility
October 16, 2026
Femtosecond laser cuts lung tumour margin assessment time
October 15, 2026
Blood sensor detects Parkinson’s-associated proteins in 40 minutes
October 15, 2026
